Yes, fault tolerance can lead to therapy resistance, one of the most significant barriers in cancer treatment. Cancer cells that survive initial treatment rounds can develop resistance through several mechanisms, such as drug efflux pumps, DNA repair enhancements, and alterations in drug targets. This resistance not only makes subsequent treatments less effective but can also result in the relapse of more aggressive and treatment-resistant cancer forms.
